Pharmaceuticals

Global Pruritus Therapeutics Industry Trends: Where the Market Is Headed by 2029

November 7, 2025 by Marketing Posting

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

How Much Was The Pruritus Therapeutics Market Worth In 2025, And What Is Its Anticipated Value By 2029?

The pruritus therapeutics market has demonstrated consistent expansion in recent years. Its valuation is set to increase from $11.89 billion in 2024 to $12.38 billion in 2025, progressing at a compound annual growth rate (CAGR) of 4.1%. This historical development can be ascribed to a rise in the occurrence of pruritus, the wide range of its causes and associated conditions, a growing elderly population, and an emphasis on enhancing patient quality of life.

The pruritus therapeutics market size is poised for substantial expansion over the next few years. It is forecast to achieve a valuation of “$15.7 billion by 2029, exhibiting a compound annual growth rate (CAGR) of 6.1%. This projected growth throughout the forecast period stems from factors such as an deepening comprehension of pruritus pathophysiology, the emergence of innovative drug formulations and delivery methods, an increased emphasis on personalized medicine, a surge in dermatological research and development activities, rising awareness and improved diagnosis rates, and a growing inclination towards botanical and herbal remedies. Significant trends anticipated during this period include the advancement of itch-specific receptor agonists and antagonists, a market-wide focus on personalized therapeutic approaches, the integration of technology for monitoring and managing itch, and increased collaborations for cross-disciplinary research.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=11907&type=smp

Which Industry Drivers Are Expected To Accelerate The Pruritus Therapeutics Market From 2025 To 2029?

An anticipated increase in the incidence of dermatological disorders is expected to drive the growth of the pruritus therapeutics market going forward. Dermatological disorders encompass conditions of the skin, hair, nails, and mucous membranes, varying from common issues like acne and eczema to more severe cases such as skin cancer and fungal infections. The specific underlying cause of itching frequently dictates the choice of pruritus treatments for these dermatological illnesses. This condition often utilizes topical treatments, emollients and moisturizers, immunosuppressant medications, and itching medications. For instance, in January 2024, the American Cancer Society, a US-based non-profit organization dedicated to eliminating cancer, reported that there would be 108,270 cases of skin cancer, reflecting a 3.2% increase from the 104,930 cases reported in 2023. Consequently, the rising occurrence of dermatological disorders is fueling the growth of the pruritus therapeutics market.

What Are The Key Segments In The Pruritus Therapeutics Market?

The pruritus therapeutics market covered in this report is segmented –

1) By Product: Corticosteroids, Antihistamines, Local Anesthetics, Counterirritants, Immunosuppressants, Calcineurin Inhibitors, Other Products

2) By Route Of Administration: Oral, Parenteral, Topical

3) By Disease Type: Atopic Dermatitis, Allergic Contact Dermatitis, Urticaria, Cutaneous T-Cell, Other Disease Types

4) By End-User: Hospitals, Clinics, Other End Users

Subsegments:

1) By Corticosteroids: Topical Corticosteroids, Systemic Corticosteroids

2) By Antihistamines: First-Generation Antihistamines, Second-Generation Antihistamines

3) By Local Anesthetics: Topical Local Anesthetics

4) By Counterirritants: Menthol-Based Products, Camphor-Based Products

5) By Immunosuppressants: Topical Immunosuppressants, Systemic Immunosuppressants

6) By Calcineurin Inhibitors: Tacrolimus Ointment, Pimecrolimus Cream

7) By Other Products: Moisturizers And Emollients, Antipruritic Herbal Remedies, Combination Therapies

How Are Trends Influencing The Pruritus Therapeutics Market?

Leading companies in the pruritus therapeutics market are focusing on developing specialized treatments for rare diseases and particular patient groups, such as those involving non-systemic ileal bile acid transport inhibitors, to deliver personalized medicine addressing unmet medical needs. A non-systemic ileal bile acid transport inhibitor is a type of drug that specifically targets bile acid absorption in the intestine, minimizing its impact on systemic circulation and thereby reducing potential side effects. As an illustration, in June 2023, Ipsen, a France-based pharmaceutical company, secured approval from the Food and Drug Administration (FDA), a US-based federal agency of the Department of Health and Human Services, for Bylvay (odevixibat). This approval is for the treatment of cholestatic pruritus in patients aged 12 months and older who have Alagille syndrome (ALGS). Bylvay, a once-daily, non-systemic ileal bile acid transport inhibitor (IBATi), demonstrates minimal systemic exposure and marks the first drug approved in the U.S. for cholestatic pruritus resulting from progressive familial intrahepatic cholestasis (PFIC). Previously approved for PFIC treatment in Europe, it is now available by prescription for eligible ALGS patients.

Who Are The Prominent Global Companies Shaping The Pruritus Therapeutics Market?

Major companies operating in the pruritus therapeutics market include Pfizer Inc., Johnson & Johnson, AbbVie Inc., Sanofi S.A., Bristol-Myers Squibb Company, Eli Lilly and Company, Regeneron Pharmaceuticals Inc., Astellas Pharma Inc. , Bausch Health Companies Inc., Galderma Laboratories LP, Cipla Limited, LEO Pharma AS, Cara Therapeutics Inc., GlaxoSmithKline Plc, Novan Inc., Escient Pharmaceuticals Inc., Nerre Therapeutic Ltd., EPI Health LLC, Trevi Therapeutics Inc., Evelo Biosciences, Toray Medical Co. Ltd.

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/pruritus-therapeutics-global-market-report

Which Geographies Are Emerging As Strong Markets For The Pruritus Therapeutics Industry?

North America was the largest region in the pruritus treatment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the pruritus therapeutics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Version Of The Pruritus Therapeutics Market Report:

https://www.thebusinessresearchcompany.com/customise?id=11907&type=smp

Browse Through More Reports Similar to the Global Pruritus Therapeutics Market 2025, By The Business Research Company

Blood Cancer Drugs Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/blood-cancer-drugs-global-market-report

Cancer Biologics Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/cancer-biologics-global-market-report

Rituximab Biosimilar Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/rituximab-biosimilar-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795